Angiographic subsegmentectomy for the treatment of patients with small hepatocellular carcinoma

Cancer

Volumn 97, Issue 4, 2003, Pages 1051-1056

  Iwamoto, Shozo ^a   Sanefuji, Hayato ^b   Okuda, Kunio ^c  

^a Iwamoto Hospital   (Japan)

^b Kitakyushu General Hospital   (Japan)

^c CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatic arterial embolization; Hepatocellular carcinoma; Lipiodol; Liver infarction; Subsegmentectomy

Indexed keywords

ALANINE AMINOTRANSFERASE; EPIRUBICIN; IODINATED POPPYSEED OIL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANGIOGRAPHIC SUBSEGMENTECTOMY; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GEL; HUMAN; HUMAN TISSUE; LIPOPHILICITY; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER PARENCHYMA; MALE; PORTAL VEIN; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME;

AGED; ANGIOGRAPHY; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 0037441621     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11106     Document Type: Article

References (22)

1. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology. 1986;6:729-738.
2. Okuda K, Takayasu K, Okada S. Management of hepatocellular carcinoma. In: Zuckerman AJ, Thomas HC, editors. Viral hepatitis. London: Churchill Livingstone, 1990:569-583.
3. Kalayci C, Johnson PJ, Raby N, et al. Intraarterial Adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous Adriamycin. J Hepatol. 1990; 11:349-353.
4. Bronowicki J-P, Vetter D, Doffoel M. Chemoembolization of hepatocellular carcinoma. In: Okuda K, Tabor E, editors. Liver cancer. London: Churchill Livingstone, 1997:463-469.
5. Matsuzaki Y, Osuga T, Saito Y, et al. A new, effective, and safe therapeutic option using proton irradiation for hepatocellular carcinoma. Gastroenterology. 1994;106:1032-1041.
6. Okuno K, Takagi H, Nakamura Y, et al. Treatment for unresectable hepatoma via selective hepatic arterial infusion of lympholine-activated killer cells generated from autologous spleen cells. Cancer. 1986;58:1001-1006.
7. Okada S. Local ablation therapy for hepatocellular carcinoma. Semin Liver Dis. 1999;19:323-328.
8. Ebara M, Ohto M, Sugiura N, et al. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients. J Gastroenterol Hepatol. 1990;5: 616-626.
9. Shibata T, Murakami T, Ogata N. Percutaneous microwave coagulation therapy for patients with primary and metastatic hepatic tumors during interruption of hepatic blood flow. Cancer. 200;88:302-311.
10. Rossi S, Buscarini E, Garbgnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Rotengenol. 1998;170:1015-1022.
11. Konno T, Maeda H, Iwai K, et al. Effect of arterial administration of high molecular -weight anticancer agent AMANCS wit lipid lymphographic agent on hepatoma: a preliminary report. Eur J Cancer Clin Oncol. 1983;10:1053-1065.
12. Maeda H, Ueda M, Morinaga T, Matsumoto T. Conjugation of poly (stylene-co-maleic acid) derivatives for the antitumor protein neocarzinostatin: pronounced improvement in pharmacological properties. J Med Chem. 1985;28:455-461.
13. Yumoto Y, Jinno K, Tokuyama K, et al. Hepatocellular carcinoma detected by iodized oil. Radiology. 1985;154:19-24.
14. Yamada R, Sato M, Kawabata M, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 1983;148:397-401.
15. Kanematsu T, Furuta T, Takenaka K, et al. A.5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology. 1989;10:98-102.
16. Takayasu K, Shima Y, Murakami Y, et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology. 1987;163:345-351.
17. Bruix J, Llovet JM, Castells A, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology. 1998;27: 1478-1583.
18. Nakamura H, Hashimoto T, Oi H, Sawada S. Iodized oil in the portal vein after arterial embolization. Radiology. 1988; 167:415-417.
19. Nakamura H, Hashimoto T, Oi H, et al. Treatment of hepatocellular carcinoma by segmental hepatic artery injection of Adriamycin-in-oil emulsion with overflow to segmental portal veins. Acta Radiol. 1990;31:347-349.
20. Wanless IR. Vascular disorders. In: MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portman EB, editors. Pathology of the liver III. London: Churchill Livingstone, 1994:539-544.
21. Takayasu K, Muramatsu Y, Maeda T, et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Rotengenol. 2001;176:681-688.
22. Takayasu K, Muramatsu Y, Moriyama N, et al. Clinical and radiological assessment of the results of hepatectomy for small hepatocellular carcinoma and therapeutic arterial embolization for postoperative recurrence. Cancer. 1989;64: 1848-1852.